Metformin’s Hidden Brain Pathway Revealed
3 min readNew DelhiMar 28, 2026 11:00 PM IST A study has uncovered a brain-related pathway for how metformin — the first-line treatment for diabetes for over 60 years and not considered to target the brain — regulates blood sugar, opening the door to more targeted therapies.“It’s been widely accepted that metformin lowers blood glucose primarily by reducing glucose output in the liver. Other studies have found that it acts through the gut,” author Makoto Fukuda, associate professor of pediatrics-nutrition at Baylor College of Medicine, US, said. “We looked into the brain as it is widely recognised as a key regulator of whole-body glucose metabolism. We investigated whether and how the brain contributes to the anti-diabetic effects of metformin,” Fukuda said. Metformin’s use in humans for treating diabetes was first reported in 1957 in France. While diabetes medications are not considered as targeting the brain, the study, published in the journal Science Advances, shows that metformin has been influencing brain pathways all along, the researchers said. “These findings open the door to developing new diabetes …


